title: Are there any differences among non-steroidal anti-inflammatory drugs? Focus on nimesulide.
abstract: Although the efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) as anti-inflammatory, analgesic and antipyretic agents is well established, there is still an open question as to whether their different pharmacokinetic and pharmacodynamic characteristics do have a different clinical impact in treating rheumatology patients. The mechanism related to the anti-inflammatory activity of these drugs is mainly related to the inhibition of the cyclo-oxygenase (COX)-2 isoform, whereas inhibition of COX-1 is associated with the side effects of these drugs. However, some NSAIDs exert their anti-inflammatory and analgesic action by additional mechanisms. The NSAID nimesulide, along with its preferential activity on COX-2 and a short half-life that correlates with a rapid onset of analgesic action, acts also through a variety of COX-independent pathways that contributes to its potent antiinflammatory and analgesic activity. The pathways affected by nimesulide include inhibition of tumour necrosis factor alpha (TNF-α) release, histamine release, reactive oxygen species production and chondrocyte death. Furthermore, the use of nimesulide has been associated with reduced levels of matrix metalloproteases and other biomarkers of joint destruction, suggesting it may have a protective effect against disease progression. Due to its multifactorial mechanism as well as to rapid onset of the analgesic action, nimesulide represents an appealing therapeutic choice for the treatment of rheumatology patients.
authors: First Clinic of Internal Medicine, University of Genova Medical School, Genova, Italy. dalle@unige.it
authors: Franco
authors: F
authors: Dallegri
authors: Luciano
authors: L
authors: Ottonello
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D001842:Bone and Bones / Q000187:drug effects; D002356:Cartilage / Q000187:drug effects; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D013449:Sulfonamides / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018836:Inflammation Mediators; D013449:Sulfonamides; C012655:nimesulide
references: Clin Pharmacokinet. 1998 Oct;35(4):247-74
references: 9812177
references: Curr Med Res Opin. 2006 Jun;22(6):1161-70
references: 16846549
references: Gut. 2001 Mar;48(3):339-46
references: 11171823
references: N Engl J Med. 2005 Mar 17;352(11):1081-91
references: 15713945
references: Eur J Clin Pharmacol. 2000 May;56(2):167-74
references: 10877012
references: J Int Med Res. 2006 Jul-Aug;34(4):348-54
references: 16989489
references: J Biol Chem. 1991 Mar 25;266(9):5625-8
references: 2005102
references: Expert Opin Pharmacother. 2001 Nov;2(11):1859-76
references: 11825322
references: Clin Evid. 2004 Dec;(12):1702-10
references: 15865742
references: Drugs. 2003;63 Suppl 1:31-6
references: 14506909
references: Drugs. 2003;63 Suppl 1:37-46
references: 14506910
references: Nature. 1996 Dec 19-26;384(6610):644-8
references: 8967954
references: Drugs R D. 2005;6(5):261-71
references: 16128596
references: Life Sci. 2001 Feb 23;68(14):1667-75
references: 11263679
references: Drugs. 1993;46 Suppl 1:22-8
references: 7506177
references: J Clin Lab Immunol. 1992;37(2):91-6
references: 1340506
references: Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7563-8
references: 10377455
references: Inflammopharmacology. 2005;13(4):343-70
references: 16354389
references: N Engl J Med. 1991 Jun 13;324(24):1716-25
references: 2034249
references: Clin Exp Rheumatol. 2001;19(1 Suppl 22):S7-11
references: 11296547
references: J Clin Invest. 2006 Jan;116(1):4-15
references: 16395396
references: Life Sci. 1998;62(22):PL 359-65
references: 9627108
references: Int J Clin Pract Suppl. 2002 Jul;(128):24-9
references: 12166616
references: Am J Ther. 2003 Nov-Dec;10(6):468-72
references: 14624289
references: N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528
references: 11087881
references: N Engl J Med. 2005 Mar 17;352(11):1071-80
references: 15713944
references: Pharmacol Rep. 2005;57 Suppl:66-85
references: 16415488
references: Nat New Biol. 1971 Jun 23;231(25):232-5
references: 5284360
references: Respiration. 1992;59(1):1-4
references: 1579712
references: Nat Rev Drug Discov. 2006 Jan;5(1):75-86
references: 16485347
references: J Thorac Cardiovasc Surg. 2003 Jun;125(6):1481-92
references: 12830070
references: N Engl J Med. 2005 Mar 17;352(11):1092-102
references: 15713943
references: Clin Pharmacokinet. 2000 Mar;38(3):225-42
references: 10749518